Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

about

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection.

P2860

Q42006963-7E83E761-C36C-41DD-AD10-3402C71DC8B4

P2860

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

Item

http://www.wikidata.org/entity/Q40669533

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

@en

type

Item

label

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

@en

prefLabel

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

@en

P1476

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

@en

P2093

Alex H Klein

http://www.w3.org/2001/XMLSchema#string

Guy Boivin

http://www.w3.org/2001/XMLSchema#string

J Jill Hopkins

http://www.w3.org/2001/XMLSchema#string

Janette I Lindley

http://www.w3.org/2001/XMLSchema#string

Jean Deschênes

http://www.w3.org/2001/XMLSchema#string

Peter Phillips

http://www.w3.org/2001/XMLSchema#string

Richard G Lalonde

http://www.w3.org/2001/XMLSchema#string

Sharon Walmsley

http://www.w3.org/2001/XMLSchema#string

Stephen D Shafran

http://www.w3.org/2001/XMLSchema#string

William G Hodge

http://www.w3.org/2001/XMLSchema#string

P2860

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy.

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.

Prevalence of visual symptoms among patients with newly diagnosed cytomegalovirus retinitis.

Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

Local therapy for cytomegalovirus retinopathy.

P304

327-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2004/369390

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18159510

http://www.w3.org/2001/XMLSchema#string

P932

2094992

http://www.w3.org/2001/XMLSchema#string

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

about

P2860

P2860

Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932